Healthcare utilization and adverse outcomes stratified by sex, age and long-term care residency using the Alberta COVID-19 Analytics and Research Database (ACARD): a population-based descriptive study

Rennert-May, Elissa; Crocker, Alysha; D’Souza, Adam G.; Zhang, Z.; Chew, Derek S.; Beall, Reed F.; Vickers, David; Leal, Jenine

doi:10.1186/s12879-023-08326-5

Cited by 7 publications

(3 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Our survey showed that younger age and not using a bronchodilator were independently associated with SARS-Co-2 infection. There was evidence showing that patients with SARS-Co-2 infection were mostly younger than 60 years ( 29 ). Bronchodilators were recommended for patients with shortness of breath according to guidelines of bronchiectasis ( 15 , 30 – 33 ).…”

Section: Discussionmentioning

confidence: 99%

Symptoms and medical resource utilization of patients with bronchiectasis after SARS-CoV-2 infection

Wang,

Ren,

et al. 2024

Front. Med.

View full text Add to dashboard Cite

BackgroundThe impact of COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on patients with bronchiectasis in terms of symptoms, self-management and medical resource utilization was unknown.ObjectiveTo describe the impact of infection by SARS-CoV-2 on fluctuation of symptoms, self-management and medical resource utilization of patients with bronchiectasis during the pandemic of COVID-19.MethodsThis was a single-center cross-sectional questionnaire study performed in Peking University Third Hospital. An online questionnaire investigation addressing the impact of SARS-CoV-2 infection on respiratory symptoms, self-management and medical resource utilization was conducted among patients with bronchiectasis during the COVID-19 surge in December 2022 in Beijing, China.ResultsFive hundred patients with bronchiectasis, with 285 (57%) females, and a mean (±SD) age of 57.9 ± 15.1 years, completed the telephone questionnaire. The reported prevalence of COVID-19 was 81.2% (406/500). Of the 406 COVID-19 patients, 89.2% experienced fever lasting mostly for no more than 3 days, 70.6 and 61.8% reported exacerbated cough and sputum production respectively, and 17.7% reported worsened dyspnea. Notable 37.4% of the patients with COVID-19 experienced symptoms consistent with the definition of an acute exacerbation of bronchiectasis. However, 76.6% (311/406) of the infected patients did not seek medical care but managed at home. Of the patients who visited hospitals, 26.3% (25/95) needed hospitalization and 2.1% (2/95) needed ICU admission. Multi-factors logistic regression analysis showed that younger age (p = 0.012) and not using a bronchodilator agent(p = 0.022) were independently associated with SARS-CoV-2 infection, while a history of exacerbation of bronchiectasis in the past year (p = 0.006) and daily use of expectorants (p = 0.002) were associated with emergency visit and/or hospitalization for patients with bronchiectasis after SARS-CoV-2 infection.ConclusionDuring the COVID-19 surge, the infection rate of SARS-CoV-2 in patients with bronchiectasis was high, and most of the patients experienced new-onset or exacerbated respiratory symptoms, but only a minority needed medical visits. Our survey results further underscore the importance of patients’ disease awareness and self-management skills during a pandemic like COVID-19.

show abstract

Section: Discussionmentioning

confidence: 99%

Symptoms and medical resource utilization of patients with bronchiectasis after SARS-CoV-2 infection

Wang,

Ren,

et al. 2024

Front. Med.

View full text Add to dashboard Cite

show abstract

“…To reduce the losses caused by irregular outbreaks of the epidemic, we need to be prepared for a certain future outbreak. Nowadays, many scholars and medical mechanisms have researched issues related to healthcare [8][9][10]. But existing research focuses more on how to quickly find response strategies after the outbreak of the epidemic.…”

Section: Introductionmentioning

confidence: 99%

Regional Healthcare Risk Analysis and Assessment Method

Li,

Xu,

Gao

2024

Preprint

View full text Add to dashboard Cite

One of the main methods for conducting regional healthcare risk analysis and decision-making is to determine healthcare risks through the analysis of environmental, social, and other data. The existing research mainly focuses on the control and management of epidemics and disasters. Compared to post-outbreak control, research on the assessment and prediction of infectious disease risks is equally important for epidemic prevention and control. This article proposed a risk analysis and assessment method based on entropy and risk weight number. Firstly, the probability and content of regional healthcare risks based on the classical risk probability is proposed. Then, starting from the influencing factors of healthcare risks, analyze the correlation between various regional factors and the risk of malignant infectious diseases, and construct a risk assessment model and method based on information entropy theory and risk weights to achieve the assessment and prediction of regional infectious disease risks. This study is an extension of the technology of intelligent data analysis in the field of healthcare and has positive significance for the research and application of intelligent technology and theory.

show abstract

“…Hospitals were overfilled, and millions of people were affected. 1 – 3 Patients with ESKD are immunocompromised 4 and, therefore, particularly vulnerable. Social distancing and isolation were the hallmark approaches to reducing exposure during the peak of the pandemic.…”

Section: Introductionmentioning

confidence: 99%

Survey of Peritoneal Dialysis Patients' Challenges and Experiences during the COVID-19 Pandemic: A Multicenter Study in the United States

AbiFaraj,

Lee,

Lacovara

et al. 2023

Kidney360

View full text Add to dashboard Cite

Background: During the COVID-19 pandemic adjustments were made to peritoneal dialysis (PD) practices in the outpatient units. These were decisions made by dialysis providers, clinical staff and governments with input from patient organizations in some instances. The patient perspective regarding these changes during the pandemic has not been explored. We sought to evaluate patient experiences and perceptions of the challenges they faced, institutional adjustments, as well as their mental health during the height of the COVID-19 pandemic in the United States. Methods: We conducted a cross-sectional survey of PD patients across four home dialysis units affiliated with four large academic centers who were on PD between March 2020 and March 2021. Results: 98 participants completed the survey across the 4 outpatient PD clinics. Over 95% of patients did not have to change their home accommodations during the pandemic, and over 80% did not have issues getting their dialysis supplies and medications delivered. Ninety-three percent of patients felt comfortable coming to the dialysis unit if they needed to during the pandemic. Almost all patients (98%) felt supported by their dialysis staff during the peak of the COVID-19 and had modified PHQ-2 (91%) and GAD-2 (96%) scores not consistent with depression or anxiety. Less than 10% of patients considered changing their dialysis modality. Conclusions: The adjustments made by the dialysis units during the peak of the pandemic were effective in maneuvering the challenges facing our patients during the COVID-19 pandemic. Overall, patients who remained on PD were satisfied with the quality of care, felt supported by the unit staff, and did not report feeling anxious or depressed.

show abstract

Healthcare utilization and adverse outcomes stratified by sex, age and long-term care residency using the Alberta COVID-19 Analytics and Research Database (ACARD): a population-based descriptive study

Cited by 7 publications

References 21 publications

Symptoms and medical resource utilization of patients with bronchiectasis after SARS-CoV-2 infection

Symptoms and medical resource utilization of patients with bronchiectasis after SARS-CoV-2 infection

Regional Healthcare Risk Analysis and Assessment Method

Survey of Peritoneal Dialysis Patients' Challenges and Experiences during the COVID-19 Pandemic: A Multicenter Study in the United States

Contact Info

Product

Resources

About